摘要
目的:探讨不同透析方式影响重组人红细胞生成素的疗效。方法:75例病人分为血液透析、腹膜透析、无透析三组。分别在用药前后测定三组病人的贫血程度(血红蛋白、红细胞、红细胞压积)。结果:同组病人用药前与用药8周后的贫血程度有显著差异性(P<0.01),但三组之间对比无差异性(P>0.05)。结论:提示重组人红细胞生成素治疗肾性贫血有明显效果,但不同透析方式不影响其疗效。
Objective: To observe varionsly dialysis way if effect the therapent of recombinant human erythropoietin(rh - Epo). Methods: 75 patient divided into hemodiolysis adepuacydialysis and pri - dialysis, bifore and after administvation, the patient of three groups were examined in the degree of anemia(Hb. RBC. Hct. ). Results: The patient of same groups, before and after administration, there is remarkable difference either in the value of Hb, RBC, Hct of the 8th week(P<0. 01), but in the three groups have no obvione difference(P >0. 05). Conclusion: rh - EPO has significant effect for renal anemia, but variously dialysis way are do not effect the therapent of rh - EPO
出处
《中国中西医结合肾病杂志》
2000年第4期216-217,共2页
Chinese Journal of Integrated Traditional and Western Nephrology
